Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3372)
All Articles published online
|
Jun 14, 2009 (publication date) through Dec 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y. A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol 2009; 15(22): 2782-2786 [PMID: 19522030 DOI: 10.3748/wjg.15.2782] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i22/2782.htm |
| Number | Citing Articles |
| 1 |
Iraj Shahramian, Ali Bazi, Rosa Mostafaee, Mohammad Hasan Mohammadi. Protective Effects of Ursodeoxycholic Acid on Valproic Acid Induced Hepatotoxicity in Epileptic Children with Recurrent Seizure; A Double-Blinded Randomized Clinical Trial. Pharmaceutical Sciences 2020; 26(1): 32 doi: 10.34172/PS.2019.62
|
| 2 |
V. Carreño. Review article: management of chronic hepatitis C in patients with contraindications to anti‐viral therapy. Alimentary Pharmacology & Therapeutics 2014; 39(2): 148 doi: 10.1111/apt.12562
|
| 3 |
O. M. Drapkina, E. L. Bueverova. Ursodeoxycholic acid: A therapeutic niche in an internist’s practice. Terapevticheskii arkhiv 2015; 87(4): 84 doi: 10.17116/terarkh201587484-90
|
| 4 |
Seonghae Yoon, Heechan Lee, Sang‐Chun Ji, Seo Hyun Yoon, Joo‐Youn Cho, Jae‐Yong Chung. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. Clinical Pharmacology in Drug Development 2021; 10(1): 68 doi: 10.1002/cpdd.790
|
| 5 |
B. Oh, W. S. Choi, S. B. Park, B. Cho, Y. J. Yang, E. S. Lee, J. H. Lee. Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi‐centre, randomised, double‐blinded, placebo‐controlled trial. International Journal of Clinical Practice 2016; 70(4): 302 doi: 10.1111/ijcp.12790
|
| 6 |
Harapan Parlindungan Ringoringo. The Role of Ursodeoxycholic Acid and Phenobarbital in a Child with Cholestasis: A Longitudinal Study. Open Access Macedonian Journal of Medical Sciences 2021; 9(C): 254 doi: 10.3889/oamjms.2021.7735
|
| 7 |
Kaveh Tabrizian, Iraj Shahramian, Ali Bazi, Mahdi Afshari, Asma Ghaemi. Alleviating Effects of Ursodeoxycholic Acid in Children with Acute Hepatitis A Infection: A Randomized Clinical Trial. Hepatitis Monthly 2019; 19(7) doi: 10.5812/hepatmon.86719
|
| 8 |
B. Kronenberger, S. Zeuzem, J. Bojunga. NASH und Hepatitis C. Der Gastroenterologe 2010; 5(2): 116 doi: 10.1007/s11377-009-0371-6
|
| 9 |
Kwang-Min Kim, Moon-Jong Kim, Sang-Wook Song, Doo-Yeoun Cho, Kyung-Chae Park, Sung-Won Yang, Young-Sang Kim, Kyung-Soo Kim. Efficacy and Safety of “URSA Complex” in Subjects with Physical Fatigue. Chinese Medical Journal 2016; 129(2): 129 doi: 10.4103/0366-6999.173432
|
| 10 |
Roman Müllenbach, Susanne N Weber, Marcin Krawczyk, Vincent Zimmer, Christoph Sarrazin, Frank Lammert, Frank Grünhage. A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-63
|
| 11 |
Yusuke Iguchi, Tomoko Nishimaki-Mogami, Masafumi Yamaguchi, Fumiteru Teraoka, Tetsuo Kaneko, Mizuho Une. Effects of Chemical Modification of Ursodeoxycholic Acid on TGR5 Activation. Biological and Pharmaceutical Bulletin 2011; 34(1): 1 doi: 10.1248/bpb.34.1
|